Nasdaq · Healthcare
VSE CORP (VSEC)
As-reported financials and recent SEC filings for VSE CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.11B
Net income
$11.7M
Net margin
1.1%
Diluted EPS
$0.55
ROE
0.8%
P/E (TTM)
76.4×
Market cap
$6.17B
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.11B | $786.3M | $544.0M | $669.4M | $481.4M |
| Gross profit | — | — | — | — | — |
| Operating income | $89.6M | $58.8M | $50.1M | $53.6M | $-2.7M |
| Net income | $11.7M | $15.3M | $39.1M | $28.1M | $8.0M |
| Diluted EPS | $0.55 | $0.85 | $2.76 | $2.19 | $0.63 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →1442026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-05-21
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →SCHEDULE 13G/A2026-05-14
View on EDGAR →8-K2026-05-08
View on EDGAR →Go deeper on VSEC
Search VSE CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.